{
  "scenario_name": "medical_ai_edge",
  "company_name": "医智科技",
  "industry": "医疗 AI",
  "product": "AI 辅助诊断系统（肺结节检测）",
  "revenue": "ARR 200万人民币",
  "team": "8人，医疗+AI 复合背景",
  "funding_need": "Pre-A 1000万人民币",
  "expected_result": "pending",
  "project_details": {
    "founding_date": "2021年6月",
    "certifications": [
      "NMPA 二类医疗器械注册证",
      "ISO 13485 质量管理体系认证"
    ],
    "technology": {
      "model": "自研深度学习模型",
      "accuracy": "92% 敏感度，95% 特异度",
      "training_data": "10万+ 标注影像数据",
      "validation": "多中心临床验证",
      "innovation": "结合影像组学和深度学习"
    },
    "market": {
      "target": "三甲医院影像科",
      "pricing": "按检查次数收费，5-10元/次",
      "tam": "200亿人民币",
      "sam": "50亿人民币",
      "competitors": [
        "推想科技",
        "依图医疗",
        "深睿医疗",
        "汇医慧影"
      ],
      "competitive_advantage": "专注肺结节细分领域，准确率较高"
    },
    "customers": {
      "hospitals": [
        "北京协和医院",
        "301医院",
        "上海瑞金医院",
        "浙江大学附属第一医院"
      ],
      "total_hospitals": 12,
      "pipeline": "正在洽谈 20+ 家医院"
    },
    "team_details": {
      "ceo": "张医生，协和医院影像科副主任医师，10年临床经验",
      "cto": "李博士，清华大学 AI 博士，5年医疗 AI 研发经验",
      "medical_advisors": 3,
      "engineers": 4,
      "sales": 1
    },
    "financials": {
      "revenue": "200万人民币/年",
      "customers": 12,
      "arpu": "16.7万/年",
      "growth_rate": "15% MoM",
      "gross_margin": "70%",
      "burn_rate": "80万/月",
      "runway": "8个月"
    },
    "milestones": {
      "completed": [
        "获得 NMPA 二类证",
        "完成多中心临床验证",
        "签约 12 家三甲医院"
      ],
      "q1_2024": "医院数量达到 30 家",
      "q2_2024": "ARR 达到 500万",
      "q3_2024": "启动三类证申请",
      "q4_2024": "拓展其他病种"
    },
    "use_of_funds": {
      "rd": "35% - 产品研发和算法优化",
      "regulatory": "20% - 三类证申请和临床试验",
      "sales": "30% - 销售团队扩张",
      "operations": "15% - 运营和管理"
    },
    "opportunities": {
      "market_growth": "医疗 AI 市场快速增长",
      "policy_support": "国家支持 AI 医疗发展",
      "clinical_need": "影像科医生工作量大，需求强烈",
      "certification": "已获得 NMPA 证，有准入资格",
      "hospital_network": "已建立头部医院客户基础"
    },
    "risks": {
      "regulatory": "高 - 医疗器械监管严格，三类证申请难度大",
      "market": "中 - 市场竞争激烈，头部公司优势明显",
      "sales_cycle": "高 - 医院采购周期长（6-12个月）",
      "reimbursement": "高 - 医保收费政策不明确",
      "technology": "中 - 算法准确率需持续提升",
      "execution": "中 - 需要平衡研发和商业化"
    },
    "concerns": [
      "营收规模较小，增长速度一般",
      "销售周期长，现金流压力大",
      "三类证申请周期长（2-3年），不确定性高",
      "医保收费政策不明确，影响商业化",
      "市场竞争激烈，头部公司资源优势明显",
      "需要持续投入研发，资金需求大"
    ],
    "strengths": [
      "已获得 NMPA 二类证，有市场准入资格",
      "团队医疗+AI 复合背景，专业能力强",
      "已签约多家头部三甲医院，有客户验证",
      "技术指标达到行业水平",
      "专注细分领域，有一定差异化"
    ],
    "decision_factors": [
      "三类证申请进展和时间表",
      "医保收费政策落地情况",
      "销售增长速度和客户质量",
      "技术指标持续提升能力",
      "团队执行力和资源整合能力"
    ]
  }
}
